Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis

Company Overview

Innovation Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing novel therapies for cancer, infectious diseases, and inflammatory conditions. The company’s drug-development programs have been based primarily on synthetic small molecules and peptide-based compounds designed to address areas of unmet medical need.

Its principal development programs have included Brilacidin, a synthetic defensin-mimetic compound investigated for potential antibacterial, anti-inflammatory, and antiviral applications, and Kevetrin, an anticancer compound designed to reactivate the tumor-suppressor protein p53. The company has also conducted development work on Prurisol, an investigational treatment for psoriasis.

Innovation Pharmaceuticals was formerly known as Cellceutix Corp. and adopted its current name in 2015. The company is based in Beverly, Massachusetts, and its securities trade over the counter under the symbol IPIX. Publicly available company materials have identified Leo Ehrlich as a longtime chief executive and corporate leader.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.05
• Volume: 6,180 shs
• Average Volume: 198,678 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:IPIX
• CIK: 1355250
• Web: ipharminc.com
• Phone: (978) 921-4125
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A